In this qualitative study of the pattern of bile acid excretion in cholestasis, methods are described for the isolation of bile acids from large volumes of urine and plasma. The bile acids were subjected to a group separation and identified by combined gas chromatography-nass spectrometry. The techniques were developed to allow identificaoion of the minor components of the bile acid mixture. Four bile acids that have not previously been described in human urine and plasma were detected, namely 3fi,7a-dihydroxy-5fi-cholan-24-oic acid, 3a,6a-dihydroxy-5fi-cholan-24-oic acid (hyodeoxycholic acid), 3a,6a,7a-trihydroxy-5fi-cholan-24-oic acid (hyocholic acid) and 3a,7fi,12a-trihydroxy5fi-cholan-24-oic acid. In addition three C27 steroids were found; 26-hydroxycholesterol and a trihydroxy cholestane, probably 5fi-cholestane-3g,7a,264triol were found in the sulphate fraction of plasma and urine. In the plasma sample, a sulphate conjugate of 24-hydroxycholesterol was found. The presence of these compounds probably reflects the existence of further pathways for bile acid metabolism. It is not yet known whether this is a consequence of the cholestasis or whether they are also present in normal man, at much lower concentrations.
In this qualitative study of the pattern of bile acid excretion in cholestasis, methods are described for the isolation of bile acids from large volumes of urine and plasma. The bile acids were subjected to a group separation and identified by combined gas chromatography-nass spectrometry. The techniques were developed to allow identificaoion of the minor components of the bile acid mixture. Four bile acids that have not previously been described in human urine and plasma were detected, namely 3fi,7a-dihydroxy-5fi-cholan-24-oic acid, 3a,6a-dihydroxy-5fi-cholan-24-oic acid (hyodeoxycholic acid), 3a,6a,7a-trihydroxy-5fi-cholan-24-oic acid (hyocholic acid) and 3a,7fi,12a-trihydroxy5fi-cholan-24-oic acid. In addition three C27 steroids were found; 26-hydroxycholesterol and a trihydroxy cholestane, probably 5fi-cholestane-3g,7a,264triol were found in the sulphate fraction of plasma and urine. In the plasma sample, a sulphate conjugate of 24-hydroxycholesterol was found. The presence of these compounds probably reflects the existence of further pathways for bile acid metabolism. It is not yet known whether this is a consequence of the cholestasis or whether they are also present in normal man, at much lower concentrations.
Patients with cholestatic liver disease have an interrupted enterohepatic circulation of bile acids. These compounds accumulate in the systemic circulation -and are excreted in the urine. The normal biliary bile acids, cholic acid (3a,7a,12a-trihydroxy5f8-cholan-24-oic acid), chenodeoxycholicacid(3a,7ac-dihydroxy-5fl-cholan-24-oic acid), deoxycholic acid (3ac,12a-dihydroxy-5fi-cholan-24-oic acid) and lithocholic acid (3a-hydroxy-5fl-cholan-24-oic acid) have have been found in the urine and plasma (Carey & Williams, 1965; Sandberg et al., 1965; Gregg, 1967; Makino et al., 1971 ). In addition, ursodeoxycholic acid (3a,7fi-dihydroxy-5fl-dolan-24-oic acid) and 3fi-hydroxychol-5-en-24-oic acid have been identified in both urine and plasma (Makino et al., 1971; Back et al., 1972; Back, 1973) , epilithocholic acid (3a-hydroxy-5a-cholan-24-oic acid) in urine (Makino et al., 1971 ) and another unsaturated monohydroxy bile acid in plasma (Murphy et al., 1972) . Van Berge Henegouwen (1974) has identified in urine, by using g.l.c. with different stationary phases, peaks with the retention times of hyocholicacid(3a,6a,7a-trihydroxy-5,8-cholan-24-oic acid) and a dihydroxy-3-oxo bile acid.
Preliminary g.l.c. studies in eight patients have confirmed that the pattern of bile acid excretion in urine, plasma and bile in cholestasis is extremely complex. Combined g.l.c.-mass spectrometry m.s.) showed that many of the peaks contained more than one compound. This paper reports experiments performed to examine the bile acid pattern in greater detail. Bile acids were extracted from large volumes of urine and plasma from two patients with primary biliary cirrhosis, subjected to a group separation and identified by g.l.c.-m.s. Four bile acids that have not been described in human urine and plasma were detected, 3/8,7cr-dihydroxy-51)-cholan-24-oic acid, 3a,6a-dihydroxy-5f8-cholan-24-oic acid (hyodeoxycholic acid), 3a,6a,7a-trihydroxy-5fi-cholan-24-oic acid (hyocholic acid) and 3a,7f8,12ca-trihydroxy-5fl-cholan-24-oic acid. In addition, 26-hydroxycholesterol and a trihydroxycholestane, probably 5f-cholestane-3a,7a,26-triol, were found in the sulphate fraction of plasma and urine. In the plasma sample, a sulphate conjugate of 24-hydroxycholesterol was found. These results support the hypothesis that there is an alternate pathway for bile acid metabolism in man, similar to that described in rats (Mitropoulos & Myant, 1967; Anderson et al., 1972 Shackleton et al. (1970) and Makino & Sjovall (1972 
Methods
Large-scale separation of bile acids from the urine and plasma samples were performed to decrease the relative contribution of background contamination and to facilitate the identification of minor components by g.l.c.-m.s.
Liquid/solidextraction. A slurry of70g ofAmberlite XAD-7 was poured into an open vertical glass column (25 cmx 1 cm) with a Teflon tap and 'backwashed' to classify the beads by size. The column was then left to settle. In contrast with Amberlite XAD-2, optimum binding of bile acids only occurred above pH 10. The bile acids were eluted with methanol. Recovery experiments with this resin, on aqueous solutions of bile acids, gave results for free bile acids of 94 %, for glycine-conjugated bile acids of 98 %, for taurine-conjugated bile acids of 87 % and for free and conjugated lithocholate sulphates of 87%. Similar recovery was obtained for bile acids added to urine (92 %) and plasma (82 Y.).
Samples (300ml) of plasma were each diluted to 1250ml with water and adjusted to pH10 with 1 M-NaOH. The urine sample (1650ml) was adjusted to pH 10 with 1 M-NaOH, and the flocculent precipitate removed by filtration. The samples were percolated through the columns of Amberlite XAD-7 (7.5ml/min) and washed with water at pH10. The resin was eluted with 100ml of methanol which was taken to dryness under reduced pressure at 60°C.
Solvolysis (Burstein & Lieberman, 1958; Palmer & Bolt, 1971) . The gummy brown residue from the methanol eluate of the resin was dissolved in 5ml of ethanol and 2.5 ml of 2M-HCl with agitation in an ultrasonic bath, and 45ml of acetone was added. The mixture was heated for 2 days at 37°C and then taken to dryness under reduced pressure. This residue was dissolved in 15ml of methanolic KOH (5g/100ml) and refluced for 1.5 h to cleave any ethyl esters formed during solvolysis. Deconjugation (Nair, 1969) . The products of solvolysis were dissolved in 2ml of methanol, 40ml of 66mM-phosphate buffer, pH 5.6, and 7ml ofclostridial cholylglycine hydrolase solution and incubated at 37°C for 1 h. The reaction was terminated by the addition of 2ml of 6M-HCl and the free bile acids were extracted with 3 x 10ml portions of ethyl acetate, dried over anhydrous Na2SO4 and taken to dryness under a stream of N2.
Group separation on Sephadex LH20. Preliminary g.l.c.-m.s. analysis of the whole samples revealed a complex bile acid mixture. A group separation was undertaken, to simplify the non-homogeneous peaks and to purify the sample further. By separating the major components, cholate and chenodeoxycholate, larger amounts of the minor components could be injected into the g.l.c.-m.s. instrument.
The free bile acid extract was methylated with either freshly prepared ethereal diazomethane for l5min or overnight in methanol/acetyl chloride (19:1, v/v). It was then dissolved in 1.5 ml of cyclohexane/ethanol (19:1, v/v), with agitation in an ultrasonic bath, and applied to an 8g column of Sephadex LH20, equilibrated with this solvent, in open vertical glass columns (25cm x 1 cm internal diam.) with Teflon taps. The column was eluted with cyclohexane/ethanol (19:1, v/v) and fractions were collected as follows: monohydroxy bile acid fraction +cholesterol (0-25ml), dihydroxy bile acid fraction (36-65ml), trihydroxy bile acid fraction (76-175 ml). Most of the pigments remained at the origin. The fractions were taken to dryness under a stream of N2 and the separations were checked by t.l.c. in a solvent system of chloroform/acetone/methanol (70:25:5, by vol.) (S VII from Hofmann, 1964) . Some trihydroxy and dihydroxy bile acids appeared in the wrong fractions so that the group separation was not complete (See Fig. 1 .) The fractions were submitted to g.l.c. and g.l.c.-m.s.
G.l.c. The O-trimethylsilyl ethers were prepared by the method of Makita & Wells (1963) . Chromatographywas performed on glass columns (2.7m x 2mm internal diam.) packed with 1 % Hi Eff 8BP on Gas Chrom Q (100-120 mesh) in a Pye 104 Series, model 64 gas chromatograph fitted with a heated flameionization detector. The conditions were: N2 carrier flow rate, 20ml/min; H2 flow rate, 20ml/min; column temperature, 235°C; detector oven and injector oven temperature, 250°C. The retention times of the bile acids, relative to methyl cholate trimethylsilyl ether were calculated from these analyses.
G.l.c.-m.s. was carried out on a Varian-Mat 731 instrument. The chromatographic conditions were similar to those used for gas chromatography. The mle scales of the illustrated spectra differ owing to Vol. 154 different paper speeds of the XY plotter (Fig. 3) . Impurities eluted from the Sephadex LH20 and silica gel 60 may account for some ofthe minor peaks in the mass spectra.
Procedure for identification of C27 steroids. Preliminary experience with g.l.c.-m.s. revealed that the samples contained C27 steroids as well as bile acids. Preparative t.l.c. was used to isolate sufficient amounts of these C27 steroids for further analysis. Silica-gel plates (0.25mm DC-Fertigplatten Kieselgel 60, Merck, Darmstadt, W. Germany) were first cleaned by continuous downward elution with methanol for 18h, dried and stored in a desiccator. The dihydroxy and trihydroxy bile acid fractions from three plasma extracts subjected to the group separation were applied to the plates and run in a solvent system of chloroform/acetone/methanol (14:5: 1, by vol.) (S VII from Hofmann, 1964 5-e4-24-oate were found. A peak with the retention time of allo-or iso-lithocholate and a mass spectrum of a monohydroxy bile acid was present but was not further identified. Apart from lithocholate and epilithocholate, which were only found in the urine specimen, the remainder of the bile acids were present in both urine and plasma.
Four more bile acids were identified in these samples. Spectra were obtained for several other bile acids but these were not fully identified mainly because of the lack of appropriate reference compounds.
3fl,7a-Dihydroxy-513-cholan-24-oate This compound was only found in the urine specimen and was eluted in the 'trihydroxy' fraction This compound was also present in the urine and plastna specimens, and was found in both the 'dihydroxy' and 'trihydroxy' fractions in the group separation. The trimethylsilyl ether derivative had the RZRTC (1.53) and mass spectrum of the authentic compound. The spectrum (Fig. 4) This compound was only found in the urine specimen and was eluted in the 'trihydroxy' fraction in the group separation. The trimethylsilyl ether derivative had the RRTC (2.00) and mass spectrum of authentic hyodeoxycholate. The spectrum (Fig. 5 A peak at mle 208 suggests this bile acid may have a 12-hydroxyl group (M-90) and mle 546 (M+). Further, the n.m.r. spectrum of the plasma compound was identical with that of authentic 26-hydroxycholesterol.
24-Hydroxycholesterol
This compound was found in the plasma sample and was eluted in the dihydroxy fraction in the group separation (compound A). The trimethylsilyl ether derivative had an RRTC of 1.59 and the mass spectrum of 24-hydroxycholesterol (Gustafsson & Sjovall, 1969 24-hydroxycholesterol (1.59) is so close to that of chenodeoxycholate (1.64) on Hi Eff 8 BP that the smaller 24-hydroxycholesterol peak is hidden under the much larger bile acid peak. This probably accounts for the failure to identify this steroid in the urine specimen since it was not subjected to the preparative-thin-layer separation.
26-Hydroxylated S5i-cholestanetriol
This compound was found in the urine and plasma samples and was eluted in the trihydroxy fraction (compound C). The trimethylsilyl ether derivative had an RRTC of 2.15. The mass spectrum showed a molecular ion at mle 636 and ions at mle 546 (M-90), mle 456 (M-2 x 90) and m/e 366 (M-3 x 90).
A prominent ion was present at mle 145. This mass spectrum was suggestive of a trihydroxylated cholestane. Evidence from n.m.r. spectrum confirmed the presence of a steroid and provided strong evidence for the presence of a 26-hydroxyl group. Further, the n.m.r. spectrum was consistent with the presence of one of the other hydroxyl groups in the 3 (a or ,B) position and the last in either the 6a or 7 (a or ff) position. The definitive identification of the structure of this compound was limited by the lack of the appropriate reference mass spectrum. To establish the state of conjugation of these three steroids, a portion of the crude serum extract from the XAD-7 extraction was silylated (Makita & Wells, 1963) silyl ethers formed were extracted into hexane in a hexane/water (1:1, v/v) partition. Analysis of this extract by g.l.c. and g.l.c.-m.s. revealed the presence of cholesterol only. The aqueous layer from this partition was taken to dryness and solvolysed as described above. The residue was silylated and the silyl ethers were again extracted into hexane. This fraction contained cholesterol, 24-hydroxycholesterol, the 26-hydroxylated cholestanetriol and 26-hydroxycholesterol. These results suggested that C27 steroids were present in the serum as solvolysable conjugates.
Discussion
The aim of this qualitative study was to identify as many components as possible of the complex mixture of bile acids and steroids present in the urine and serum in cholestasis. These studies of the pattern of bile acid excretion in cholestasis were not exhaustive. The methods used were inappropriate for the identification of ketonic bile acids, and bile acids or cholesterol derivatives with more than three hydrdxyl groups in the steroid ring. However, it is noteworthy that these investigations on the urine and serum from two different patients have shown, in general, a qualitative similarity in the bile acid pattern in the two samples. 
Methodology
The identification of minor bile acid components in biological fluids requires procedures that give a high degree of purification without introducing contamination. Amberlite XAD-7 was selected since it produced only trivial background contamination on g.l. (1972) and Back (1973) in finding ursodeoxycholate and 3,6-hydroxychol-5-en-24-oate in both urine and plasma in cholestasis.
C27 steroids 26-Hydroxycholesterol was found in both urine and plasma probably as a sulphate conjugate. This compound has been found in the urine of patients with biliary atresia (Makino et al., 1971) and in the faeces of infants under 4 months old, but not in older infants (Gustafsson & Sjovall, 1969) .
In the rat, an alternative pathway for the synthesis of chenodeoxycholic and 6-a-hydroxylated bile acids, where the formation of 26-hydroxycholesterol is the first committed step, has been demonstrated by Mitropoulos & Myant (1967) . Anderson et.al. (1972) have shown that 26-hydroxycholesterol can be metabolized to bile acids in man. It is therefore possible that the 26-hydroxycholesterol present in specimens from our two patients may be the precursors of bile acids.
The cholestanetriol found in both the urine and serum was also present as a sulphate. Evidence from n.m.r. pointed strongly to this compound having one hydroxyl group in the 26 position, It is possible that the compound was 5fi-cholestane-3a,7a,26-triol, an 1976 intermediate in the normal pathway for bile acid synthesis (Danielsson, 1973) . However, confirmation of this structure must await appropriate reference mass spectra.
The third C27 steroid found in the serum was 24-hydroxycholesterol. Failure to detect it in the urine was probably tehnical since it would have been obscured by the much larger chenodeoxycholate peak on g.l.c. This compound has been identified in the urine of patients with biliary atresia (Makino etal., 1971) . A sulphate ester of24-hydroxycholesterol has been found in the faeces of infants (Gustafsson & Sj6vall, 1969) , The metabolic fate of this compound in man is unknown.
&Hydroxylated bile acids
Hyocholate was ideiitified in both the urine and serum specimens and hyodeoxycholate in the urine specimen: both of these bile acids were present in small amounts. Hyocholate and lithocholate were present in similar atnounts, but only traces of hyodeoxycholate were found.-To obtain a satisfactory mass spectrum for hyodeoxycholate, it was necessary to extract bile acids from large volumes of urine for purification and subsequent group separation. Apart from the observations of Van Berge Henegouwen (1974) of hyocholate in urine in cholestasis, 6a-hydroxylated bile acids have not been found in man. In this respect, it is noteworthy that Triilzsch et al. (1974) found that human liver microsomal preparations were capable of 6a-hydroxylating lithocholate (3 a-hydroxy-5fi-cholan-24-oate) to hyodeoxycholate (3a,6a-dihydroxy-5fi-cholan-24-oate) although Bjorkhem et al. (1973) were unable to confirm these observations. The presence of 6a-hydroxylated bile acids in cholestasis in addition to 26-hydroxycholesterol, 3a-hydroxychol-5-en-24-oate and lithocholate, lends support to the view that an alternative pathway such as that suggested by Mitropoulos & Myant (1967) may exist in this condition.
3fl,7c-Dihydroxy-5,8-cholan-24-oate and 3a,7fl,l2a-trihydroxy-Sf-cholan-24-oate
Although there was no clinical evidence of a urinary-tract infection in either patient, the formation of 3fl,7a-dihydroxy-5f8-cholan-24-oate could have resulted from infection since it was only found in the urine specimen. This bile acid has been found in human faeces (Eneroth et al., 1966) . 3a,7fl,12at-Trihydroxy-5fl-cholan-24-oate was found in both the urine and serum specimen. On g.l.c. this compound (RRTC 1.53) runs close to deoxycholate (RRTC 1.51) and may have been confused with deoxycholate in some previous studies, although it has been found in human bile (Sjovall, 1959) and faeces (Hirofugi, 1965 epimer of chenodeoxycholate (ursodeoxycholate) has been found in the urine of a child with biiary atresia and no significant enterohepatic circulation (Back, 1971) . Ursodeoxycholate has also been found in the urine and serum ofthe patients we have studied. These observations support an hepatic origin for the 7, epimers ofcholate and chenodeoxycholate found.
Conclusion
The finding of large numbers of bile acids and C27 steroids raises many questions about bile acid metabolism in the cholestatic syndrome. First, whether they are synthesized in the liver at all or are formed as the result of bacterial action in the bowel owing to an incomplete cholestasis, and are then reabsorbed and presented to an incompetent liver so that the plasma concentration rises. Secondly, the unusual bile acids could be the result of an occult urinary-tract infection. Thirdly, it is conceivable that the kidney has a metabolic role and that some of the epimers may be formed in the kidney.
If these numerous bile acids and C27 steroids are synthesized de novo in the liver, they must reflect further metabolic pathways. The question then arises as to whether their presence is the result of cholestasis or whether they also occur in normal individuals but at concentrations too low for detection by currently available techniques.
